Stryker Corporation Stock price

Equities

SYK

US8636671013

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:01 2024-03-18 pm EDT 5-day change 1st Jan Change
354.1 USD +0.53% Intraday chart for Stryker Corporation -0.42% +18.24%
Sales 2024 * 22.17B Sales 2025 * 23.8B Capitalization 135B
Net income 2024 * 3.87B Net income 2025 * 4.24B EV / Sales 2024 * 6.42 x
Net Debt 2024 * 7.59B Net Debt 2025 * 5.06B EV / Sales 2025 * 5.87 x
P/E ratio 2024 *
35.5 x
P/E ratio 2025 *
31.9 x
Employees 52,000
Yield 2024 *
0.9%
Yield 2025 *
0.98%
Free-Float 93.45%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.53%
1 week-0.42%
Current month+1.44%
1 month+1.37%
3 months+21.48%
6 months+20.76%
Current year+18.24%
More quotes
1 week
350.79
Extreme 350.79
359.65
1 month
346.04
Extreme 346.0442
361.41
Current year
292.43
Extreme 292.43
361.41
1 year
249.98
Extreme 249.98
361.41
3 years
188.84
Extreme 188.84
361.41
5 years
124.54
Extreme 124.54
361.41
10 years
75.78
Extreme 75.78
361.41
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 11-04-24
Director of Finance/CFO 62 02-12-31
Compliance Officer - 16-12-31
Members of the board TitleAgeSince
Director/Board Member 80 73-12-31
Director/Board Member 65 18-05-01
Director/Board Member 89 77-01-31
More insiders
Date Price Change Volume
24-03-18 354.1 +0.53% 953,753
24-03-15 352.2 -0.96% 2,075,224
24-03-14 355.6 -0.35% 961,235
24-03-13 356.9 -0.42% 1,105,232
24-03-12 358.4 +0.79% 737,022

Delayed Quote Nyse, March 18, 2024 at 04:00 pm EDT

More quotes
Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
354.1 USD
Average target price
356.8 USD
Spread / Average Target
+0.76%
Consensus
  1. Stock
  2. Equities
  3. Stock Stryker Corporation - Nyse